Healthcare and life sciences (HLS) organizations face challenges with inefficient document workflows that lead to operational ineffectiveness, errors, and compliance problems
To address these issues WinWire built an intelligent clinical document automation solution that can greatly enhance the quality of medical documentation to meet regulatory standards and guidelines.
WinWire’s Clinical Document Automation Solution leverages Generative AI and natural language generation (NLG) to revolutionize drug development. By streamlining the creation and review of clinical trial documents, our platform speeds up time-to-market for new drugs and significantly reduces the risk of human error.
The solution generates documents such as informed consent forms and clinical study reports that comply with regulatory standards set by the FDA, EMA, and ICH, ensuring that users meet regulatory requirements.
Detects errors, inconsistencies, and deviations from regulatory standards that human reviewers mistakenly overlook.
Document review times are significantly reduced. This improved efficiency leads to shorter lead times for launching clinical trials and bringing new drugs to market.
Identifies potential safety concerns or ethical issues within clinical trial protocols. It can cross-reference historical data, adverse event reports and best practices.
Minimize review cycles with automation that generates formatted documents, reducing errors and the need for extensive edits.
Consider our GenAI powered solution to boost efficiency, cut costs, and accelerate time-market for new drug development.
Let’s discuss how we can help you create digital experiences
